This chapter contains sections titled: Introduction Peptide Drugs Technologies Used for Reducing in vivo Clearance of Therapeutic Peptides Fc-Fusion Proteins in Drug Development Peptide-Fc-Fusion Therapeutics Considerations and Challenges for Engineering Peptide-Fc-Fusion Therapeutics Conclusions Acknowledgment References